Analyst Ratings for Rhythm Pharmaceuticals (RYTM) [Sells]

RYTM Rating Summary

RYTM Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RYTM
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $50.75 (+125%) * Over Last 12-Mos
Rating Score: 7.5 / 10   Percentile Rank: 78%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/8/2020 Goldman Sachs Graig Suvannavejh New Coverage Sell
(N/A)
18.00
(N/A)
22.34
(22.56)
0.98% Details
Like RYTM Ratings? Also take a look at GMDA, PEG

RYTM Ratings News